NCT01329536 · COMPLETED
The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
This study looks at whether the APOE4 gene variant is more common in people with late-onset Alzheimer's who show agitation than in those who do not. Researchers compare genetic test results between the two groups. No drug or treatment is being tested. It is an observational study, so there is no phase.
You may qualify if
- Men and women who are at least 65 years of age
- Meet the DSM-IV-TR criteria for late-onset Alzheimer's Disease (AD)
You're excluded if
- Unable to provide informed consent or do not have a legally acceptable caregiver and/or representative present or available to enter into the informed consent process on the study subject's behalf
- Diagnosis of a non-Alzheimer's type of dementia
- Determined by the Principal Investigator (or his designee) that the study subject would be unsuitable for study participation
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2011-10-06